Fundraising Fox

Srini Akkaraju

Investor

Managing Partner at Samsara BioCapital

Burlingame, California

Writes $10M – $100M checks · typically $25M

FoundedA2 BiotherapeuticsChinook Therapeutics U.S

Experience

  1. Samsara BioCapitalManaging General Partnercurrent2017 — present
  2. Sofinnova VenturesGeneral Partner2013 — 2016Menlo Park
  3. New Leaf Venture PartnersManaging Director2009 — 2013
  4. Panorama CapitalManaging Director2006 — 2008
  5. JPMPAssociate, Principal, Partner2001 — 2006
  6. GenentechManager, BD1998 — 2001
  7. GentenchBusiness Development1998 — 2001

Education

  1. Stanford UniversityMD, PhD1990 — 1998
  2. Stanford University School of MedicineMD, PhD1990 — 1998
  3. Rice UniversityBA, Biochemistry; Computer Science1986 — 1990

Deals · 3

A2 BiotherapeuticsBoard seat

via Samsara BioCapital · filed Oct 2020 · $71.5M raise

Chinook Therapeutics U.SBoard seat

via Samsara BioCapital · filed Aug 2019 · $65M raise

aTYR PHARMABoard seat

via Samsara BioCapital · filed Sep 2017 · $45.8M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Samsara BioCapital

Abe Bassan
Principal at Samsara BioCapital
Cory Freedland
Investor at Samsara BioCapital
Marcos Milla
Venture Partner at Samsara BioCapital
Mike Dybbs
Partner at Samsara BioCapital
Robert Baffi
Venture Partner at Samsara BioCapital

Network2

Christina Isacson
Partner at Lightstone Ventures
Dayton Thorpe
Angel

Investors connected to Srini in public investor directories — a warm-intro map.

Frequently asked questions

Where does Srini Akkaraju work?
Srini Akkaraju is Managing Partner at Samsara BioCapital.
What check size does Srini Akkaraju write?
Srini Akkaraju typically writes checks of $10M – $100M.
What companies did Srini Akkaraju found?
Srini Akkaraju founded A2 Biotherapeutics, Chinook Therapeutics U.S.

Same school

Also attended Stanford University2,000

Peter ThielCo-founder & Partner at Founders FundReid HoffmanCo-founder of LinkedIn; Partner at GreylockDavid SacksCo-founder & General Partner at Craft Ventures; PCAST co-chair; former White House AI & crypto czarKeith RaboisManaging Director at Khosla VenturesGarry TanPresident & CEO of Y CombinatorAlfred LinPartner at Sequoia Capital

+ 1,994 more

Also attended Stanford University School of Medicine77

Jeffrey FinerVenture Partner at Third Rock VenturesRebecca MancusiInvestor at Third Rock VenturesSebastian CaliriInvestment Team at 8VCAlex MorganInvestor at Khosla VenturesLauren PopovAssociate at Westlake Village BioPartnersClare OzawaManaging Director at Versant Ventures

+ 71 more

Also attended Rice University129

Abigail JohnsonPartner, Chief Operating Officer at Sapphire VenturesEdi DanalacheSenior Associate at Scale Venture PartnersJim BridenstineManaging Partner, Artemis Group at Cortado VenturesPatrick OkoraforDirector of Finance at Mercury FundSharon KedarCo-Founder, Partner at Northpond VenturesMartin ScottSenior Technical Advisor at Samsung Catalyst Fund

+ 123 more

Shared employers

Also worked at Sofinnova Ventures9

Jonathan BurbaumEntrepreneur-In-Residence at The Innovation SpaceLars EkmanExecutive Partner, Private Equity at Sofinnova VenturesPerry NisenExecutive Advisor, Private Equity at Sofinnova VenturesJonathan LeffExecutive Partner, Private Equity at Sofinnova VenturesBrian WilcoveManaging Partner at America's Frontier FundEric BuatoisGeneral Partner at Benhamou Global Ventures

+ 3 more

Also worked at New Leaf Venture Partners6

Mike DybbsPartner at Samsara BioCapitalDoug Fisher, MDPartner at Revelation PartnersIsaac MankePartner at ACORN BIOVENTURESEliot CharlesPartner at Apax DigitalAsha NayakInvestor at Johnson & Johnson Innovation – JJDCLiam RatcliffeGeneral Partner at New Leaf Venture Partners

Also worked at Genentech95

David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures

+ 89 more